52-Week Low Club (ALO, AEIS, CAMD, DGII, DLX, EBAY, IPCS, MRCY, MTSC, PRS, RJF, THQI, VRTX)

Print Email

Yesterday saw many stocks hitting 52-week lows and then a sharp recovery with a low to high swing of more than 500 DJIA points.  Here are some of the stocks that hit 52-week lows today:

  • Alpharma (ALO) fell over 2% to a new 52-week low.
  • Advanced Energy (AEIS) continued its slide after disappointing earnings this week.
  • California Micro Devices Corp. (CAMD) slid 6% and even more intraday two days after earnings.
  • Digi International (DGII) fell over 10% after earnings.
  • Deluxe Corp. (DLX) didn’t look so deluxe today after a near 15% drop in earnings and a "raised guidance" that was more in-line with estimates.
  • eBay (EBAY) earnings guidance (and somewhat from the Meg Whitman departure) along with some late downgrades contributed to eBay’s new 52-week lows.
  • iPCS (IPCS) saw another tumble today.  Guess who is a Sprint reseller and guess which cellular company is under fire and announced store closures and third part closures? This looks like the Boulevard of Broken Dreams.
  • Mercury Computer Systems (MRCY) was one of the biggest percentages losers with a 30+% drop after yesterday’s earnings. This manufacturer of computer and software for embedded systems might want to change their name to Mercy Systems.
  • MTS Systems (MTSC) saw a sharp drop of roughly 15% after its earnings and "reaffirmed guidance" failed to impress.
  • Primus Guaranty Ltd. (PRS) is now down nearly two-thirds from highs, although it appears that it isn’t closing on 52-week lows even after an almost 10% drop.  Guess who sells credit swaps for their living?
  • Raymond James (RJF) saw close to a 10% drop after yesterday’s numbers.
  • THQ inc. (THQI) showed not all game makers are equal after it has write-offs from title discontinuations with almost a 30% price drop today.
  • Vertex Pharma (VRTX) spent much of the day at 52-week lows although it clawed back above the $19.13 low at the end of the trading session.  This was at a 2-year low yesterday on a hepatitis-C trial timing issue.  Citigroup downgraded it today.

Jon C. Ogg
January 24, 2008